EUCTR2004-002778-50-ITActive, not recruitingNot Applicable
A multi-national, open labelled, randomized, stratified, parallel group 36 week comparison of twice daily Biphasic Insulin Aspart 30 versus thrice daily Biphasic Insulin Aspart 50 and 70 all in combination with metformin in subjects with diabetes type 2
OVO NORDISK0 sitesStarted: May 18, 2005Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Active, not recruiting
Not Applicable
A multi-national, open labelled, randomised, stratified, parallel group 36 week comparison of twice daily Biphasic Insulin Aspart 30 versus thrice daily Biphasic Insulin Aspart 50 and 70 all in combination with metformin in subjects with type 2 diabetes. (INTENSIMIX-trial) - INTENSIMIX-trialEUCTR2004-002778-50-DKovo Nordisk A/S750
Active, not recruiting
Not Applicable
A multi-national, open labelled, randomised, stratified, parallel group 36 week comparison of twice daily Biphasic Insulin Aspart 30 versus thrice daily Biphasic Insulin Aspart 50 and 70 all in combination with metformin in subjects with type 2 diabetes. (INTENSIMIX-trial)EUCTR2004-002778-50-BEovo Nordisk A/S750
Active, not recruiting
Phase 1
A multi-national, open labelled, randomised, stratified, parallel group 36 week comparison of twice daily Biphasic Insulin Aspart 30 versus thrice daily Biphasic Insulin Aspart 50 and 70 all in combination with metformin in subjects with type 2 diabetes. (INTENSIMIX-trial) - INTENSIMIX-trialEUCTR2004-002778-50-ESovo Nordisk A/S
Active, not recruiting
Phase 1
A multi-national, open labelled, randomised, stratified, parallel group 36 week comparison of twice daily Biphasic Insulin Aspart 30 versus thrice daily Biphasic Insulin Aspart 50 and 70 all in combination with metformin in subjects with type 2 diabetes. (INTENSIMIX-trial)EUCTR2004-002778-50-GBovo Nordisk A/S
Active, not recruiting
Phase 1
A multi-national, open labelled, randomised, stratified, parallel group 36 week comparison of twice daily Biphasic Insulin Aspart 30 versus thrice daily Biphasic Insulin Aspart 50 and 70 all in combination with metformin in subjects with type 2 diabetes. (INTENSIMIX-trial)Type 2 diabetesMedDRA version: 7.0Level: LLTClassification code 10045242EUCTR2004-002778-50-HUovo Nordisk A/S